{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:34:31Z","timestamp":1787024071361,"version":"build-2736575974"},"reference-count":39,"publisher":"Japanese Society of Toxicology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2022]]},"DOI":"10.2131\/jts.47.89","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T17:15:17Z","timestamp":1646241317000},"page":"89-98","source":"Crossref","is-referenced-by-count":10,"title":["Development of &lt;i&gt;in silico&lt;\/i&gt; prediction models for drug-induced liver malignant tumors based on the activity of molecular initiating events: Biologically interpretable features"],"prefix":"10.2131","volume":"47","author":[{"given":"Kota","family":"Kurosaki","sequence":"first","affiliation":[{"name":"Department of Medical Molecular Informatics, Meiji Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Uesawa","sequence":"additional","affiliation":[{"name":"Department of Medical Molecular Informatics, Meiji Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aguirre-Plans, J., Pi\u00f1ero, J., Souza, T., Callegaro, G., Kunnen, S.J., Sanz, F., Fernandez-Fuentes, N., Furlong, L.I., Guney, E. and Oliva, B. (2021): An ensemble learning approach for modeling the systems biology of drug-induced injury. Biol. Direct, <b>16<\/b>, 5.","DOI":"10.1186\/s13062-020-00288-x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Amano, Y., Honda, H., Sawada, R., Nukada, Y., Yamane, M., Ikeda, N., Morita, O. and Yamanishi, Y. (2020): In silico systems for predicting chemical-induced side effects using known and potential chemical protein interactions, enabling mechanism estimation. J. Toxicol. Sci., <b>45<\/b>, 137-149.","DOI":"10.2131\/jts.45.137"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Anstee, Q.M., Reeves, H.L., Kotsiliti, E., Govaere, O. and Heikenwalder, M. (2019): From NASH to HCC: current concepts and future challenges. Nat. Rev. Gastroenterol. Hepatol., <b>16<\/b>, 411-428.","DOI":"10.1038\/s41575-019-0145-7"},{"key":"4","unstructured":"Bergstra, J., Yamins, D. and Learning, D.C. (2013): Making a science of model search: hyperparameter optimization in hundreds of dimensions for vision architectures. PMLR, <b>13<\/b>, 115-123."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Bettermann, K., Vucur, M., Haybaeck, J., Koppe, C., Janssen, J., Heymann, F., Weber, A., Weiskirchen, R., Liedtke, C., Gassler, N., M\u00fcller, M., de Vos, R., Wolf, M.J., Boege, Y., Seleznik, G.M., Zeller, N., Erny, D., Fuchs, T., Zoller, S., Cairo, S., Buendia, M.A., Prinz, M., Akira, S., Tacke, F., Heikenwalder, M., Trautwein, C. and Luedde, T. (2010): TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell, <b>17<\/b>, 481-496.","DOI":"10.1016\/j.ccr.2010.03.021"},{"key":"6","unstructured":"Cawley, G.C. and Talbot, N.L. (2010): On over-fitting in model selection and subsequent selection bias in performance evaluation. J. Mach. Learn. Res., <b>11<\/b>, 2079-2107."},{"key":"7","doi-asserted-by":"crossref","unstructured":"Chen, M., Suzuki, A., Thakkar, S., Yu, K., Hu, C. and Tong, W. (2016): DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov. Today, <b>21<\/b>, 648-653.","DOI":"10.1016\/j.drudis.2016.02.015"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Diamanti-Kandarakis, E., Bourguignon, J.P., Giudice, L.C., Hauser, R., Prins, G.S., Soto, A.M., Zoeller, R.T. and Gore, A.C. (2009): Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev., <b>30<\/b>, 293-342.","DOI":"10.1210\/er.2009-0002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Fawcett, T. (2006): An Introduction to ROC Analysis. Pattern Recognit. Lett., <b>27<\/b>, 861-874.","DOI":"10.1016\/j.patrec.2005.10.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Fox, J.T., Sakamuru, S., Huang, R., Teneva, N., Simmons, S.O., Xia, M., Tice, R.R., Austin, C.P. and Myung, K. (2012): High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. Proc. Natl. Acad. Sci. USA, <b>109<\/b>, 5423-5428.","DOI":"10.1073\/pnas.1114278109"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Gadaleta, D., Manganelli, S., Roncaglioni, A., Toma, C., Benfenati, E. and Mombelli, E. (2018): QSAR modeling of ToxCast assays relevant to the molecular initiating events of AOPs leading to hepatic steatosis. J. Chem. Inf. Model., <b>58<\/b>, 1501-1517.","DOI":"10.1021\/acs.jcim.8b00297"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Ghosh, A., Ghosh, S., Dasgupta, D., Ghosh, A., Datta, S., Sikdar, N., Datta, S., Chowdhury, A. and Banerjee, S. (2016): Hepatitis B virus X protein upregulates hELG1\/ ATAD5 expression through E2F1 in hepatocellular carcinoma. Int. J. Biol. Sci., <b>12<\/b>, 30-41.","DOI":"10.7150\/ijbs.12310"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Gionfra, F., De Vito, P., Pallottini, V., Lin, H.Y., Davis, P.J., Pedersen, J.Z. and Incerpi, S. (2019): The role of thyroid hormones in hepatocyte proliferation and liver cancer. Front. Endocrinol. (Lausanne), <b>10<\/b>, 532.","DOI":"10.3389\/fendo.2019.00532"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Hardt, A., Stippel, D., Odenthal, M., H\u00f6lscher, A.H., Dienes, H.P. and Drebber, U. (2012): Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report. Case Rep. Pathol., <b>2012<\/b>, 195607.","DOI":"10.1155\/2012\/195607"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Hassan, M.M., Botrus, G., Abdel-Wahab, R., Wolff, R.A., Li, D., Tweardy, D., Phan, A.T., Hawk, E., Javle, M., Lee, J.S., Torres, H.A., Rashid, A., Lenzi, R., Hassabo, H.M., Abaza, Y., Shalaby, A.S., Lacin, S., Morris, J., Patt, Y.Z., Amos, C.I., Khaderi, S.A., Goss, J.A., Jalal, P.K. and Kaseb, A.O. (2017): Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma. Clin. Gastroenterol. Hepatol., <b>15<\/b>, 1791-1799.","DOI":"10.1016\/j.cgh.2017.05.036"},{"key":"16","doi-asserted-by":"crossref","unstructured":"He, S., Ye, T., Wang, R., Zhang, C., Zhang, X., Sun, G. and Sun, X. (2019): An in silico model for predicting drug-induced hepatotoxicity. Int. J. Mol. Sci., <b>20<\/b>, 1897.","DOI":"10.3390\/ijms20081897"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Herman, M., Weinstein, T., Korzets, A., Chagnac, A., Ori, Y., Zevin, D., Malachi, T. and Gafter, U. (2001): Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J. Lab. Clin. Med., <b>137<\/b>, 14-20.","DOI":"10.1067\/mlc.2001.111469"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Hong, H., Thakkar, S., Chen, M. and Tong, W. (2017): Development of decision forest models for prediction of drug-induced liver injury in humans using a large set of FDA-approved drugs. Sci. Rep., <b>7<\/b>, 17311.","DOI":"10.1038\/s41598-017-17701-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Huang, S.H. and Tung, C.W. (2017): Identification of consensus biomarkers for predicting non-genotoxic hepatocarcinogens., 7, 41176.","DOI":"10.1038\/srep41176"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Inokuchi, S., Aoyama, T., Miura, K., Osterreicher, C.H., Kodama, Y., Miyai, K., Akira, S., Brenner, D.A. and Seki, E. (2010): Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc. Natl. Acad. Sci. USA, <b>107<\/b>, 844-849.","DOI":"10.1073\/pnas.0909781107"},{"key":"21","first-page":"52","author":"T. Kogiso","year":"2018","unstructured":"Kogiso, T., Sagawa, T., Kodama, K., Taniai, M., Katagiri, S., Egawa, H., Yamamoto, M. and Tokushige, K. (2018): Hepatocellular carcinoma after direct-acting antiviral drug treatment in patients with hepatitis C virus. JGH Open, <b>3<\/b>, 52-60.","journal-title":"JGH Open","ISSN":"https:\/\/id.crossref.org\/issn\/2397-9070","issn-type":"print"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Kurosaki, K., Wu, R. and Uesawa, Y. (2020): A toxicity prediction tool for potential agonist\/antagonist activities in molecular initiating events based on chemical structures. Int. J. Mol. Sci., <b>21<\/b>, 7853.","DOI":"10.3390\/ijms21217853"},{"key":"23","doi-asserted-by":"publisher","unstructured":"Kurosaki, K. and Uesawa, Y. (2021): Molecular initiating events associated with drug-induced liver malignant tumors: an integrated study of the FDA adverse event reporting system and toxicity predictions. Biomolecules, <b>11<\/b>, 944.","DOI":"10.3390\/biom11070944"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Laprise, C., Cahoon, E.K., Lynch, C.F., Kahn, A.R., Copeland, G., Gonsalves, L., Madeleine, M.M., Pfeiffer, R.M. and Engels, E.A. (2019): Risk of lip cancer after solid organ transplantation in the United States. Am. J. Transplant., <b>19<\/b>, 227-237.","DOI":"10.1111\/ajt.15052"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Liu, Z., Zhu, L., Thakkar, S., Roberts, R. and Tong, W. (2020): Can Transcriptomic Profiles from Cancer Cell Lines Be Used for Toxicity Assessment? Chem. Res. Toxicol., <b>33<\/b>, 271-280.","DOI":"10.1021\/acs.chemrestox.9b00288"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Luedde, T. and Schwabe, R.F. (2011): NF-\u03baB in the liver--linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol., <b>8<\/b>, 108-118.","DOI":"10.1038\/nrgastro.2010.213"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C. and Pasparakis, M. (2007): Deletion of NEMO\/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell, <b>11<\/b>, 119-132.","DOI":"10.1016\/j.ccr.2006.12.016"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Matthews, B.W. (1975): Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim. Biophys. Acta, <b>405<\/b>, 442-451.","DOI":"10.1016\/0005-2795(75)90109-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Mizushima, T. and Miyamoto, H. (2019): The Role of Androgen Receptor Signaling in Ovarian Cancer. Cells, <b>8<\/b>, 176.","DOI":"10.3390\/cells8020176"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Namani, A., Li, Y., Wang, X.J. and Tang, X. (2014): Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer. Biochim. Biophys. Acta, <b>1843<\/b>, 1875-1885.","DOI":"10.1016\/j.bbamcr.2014.05.003"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Onakpoya, I.J., Heneghan, C.J. and Aronson, J.K. (2016): Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med., <b>14<\/b>, 10.","DOI":"10.1186\/s12916-016-0553-2"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Ranhotra, H.S. (2015): Estrogen-related receptor alpha and cancer: axis of evil. J. Recept. Signal Transduct. Res., <b>35<\/b>, 505-508.","DOI":"10.3109\/10799893.2015.1049362"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Safe, S., Lee, S.O. and Jin, U.H. (2013): Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target. Toxicol. Sci., <b>135<\/b>, 1-16.","DOI":"10.1093\/toxsci\/kft128"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Solbach, P., Potthoff, A., Raatschen, H.J., Soudah, B., Lehmann, U., Schneider, A., Gebel, M.J., Manns, M.P. and Vogel, A. (2015): Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report. BMC Gastroenterol., <b>15<\/b>, 60.","DOI":"10.1186\/s12876-015-0288-0"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Stoot, J.H., Coelen, R.J., De Jong, M.C. and Dejong, C.H. (2010): Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford), <b>12<\/b>, 509-522.","DOI":"10.1111\/j.1477-2574.2010.00222.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Wang, Y., Xiao, Q., Chen, P. and Wang, B. (2019): In silico prediction of drug-induced liver injury based on ensemble classifier method. Int. J. Mol. Sci., <b>20<\/b>, 4106.","DOI":"10.3390\/ijms20174106"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Woodward, C., Smith, J., Acreman, D. and Kumar, N. (2019): Hepatocellular carcinoma in body builders; an emerging rare but serious complication of androgenic anabolic steroid use. Ann. Hepatobiliary Pancreat. Surg., <b>23<\/b>, 174-177.","DOI":"10.14701\/ahbps.2019.23.2.174"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Yamada, F., Sumida, K. and Saito, K. (2016): An improved model of predicting hepatocarcinogenic potential in rats by using gene expression data. J. Appl. Toxicol., <b>36<\/b>, 296-308.","DOI":"10.1002\/jat.3184"},{"key":"39","doi-asserted-by":"publisher","unstructured":"Zhu, X. and Kruhlak, N.L. (2014): Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data. Toxicology, <b>321<\/b>, 62-72.","DOI":"10.1016\/j.tox.2014.10.008"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/47\/3\/47_89\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T23:14:07Z","timestamp":1646435647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/47\/3\/47_89\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.47.89","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}